SGRY analyst estimates

Surgery Partners (SGRY) analyst ratings, the average price target and its range, and every firm's latest call.

SGRY analyst ratings and price targets

DateFirmCallTarget
Oct 26, 2026RBC CapitalSurgery Partners downgraded to Sector Perform from Outperform at RBC Capital$23.50
Oct 26, 2026Raymond JamesSurgery Partners downgraded to Neutral from Overweight at Cantor Fitzgerald$23.50
Aug 11, 2026RBC CapitalSurgery Partners price target lowered to $19 from $20 at RBC Capital$19.00
Aug 11, 2026Raymond JamesCantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY), Highlights Improved Cash Conversion$18.00
May 6, 2026JefferiesSurgery Partners price target raised to $17 from $15 at Jefferies$17.00
Apr 20, 2026JefferiesSurgery Partners price target lowered to $15 from $16.25 at Jefferies$15.00
Mar 11, 2026US Capital AdvisorsUBS Reiterates Buy Rating on Surgery Partners (SGRY) Following Activist Letter to Shareholders$21.00
Mar 4, 2026RBC CapitalSurgery Partners (SGRY) PT Lowered at RBC Capital as 2026 Guide Prompts Selloff$20.00
Mar 4, 2026JefferiesSurgery Partners (SGRY) PT Lowered to $16.25 at Jefferies$16.25
Mar 3, 2026JefferiesBenchmark Reiterates Buy Rating on Surgery Partners (SGRY) Following Q4 Results$30.00
Dec 18, 2025Mizuho SecuritiesSurgery Partners price target lowered to $19 from $22 at Mizuho$19.00
Nov 21, 2025BarclaysSurgery Partners price target lowered to $18 from $24 at Barclays$18.00
Nov 17, 2025Mizuho SecuritiesSurgery Partners price target lowered to $22 from $28 at Mizuho$22.00
Nov 13, 2024BarclaysSurgery Partners (SGRY) PT Lowered to $31 at Barclays$31.00
Nov 13, 2024JefferiesSurgery Partners (SGRY) PT Lowered to $40 at Jefferies$40.00

Updated 2026-11-03 00:02 UTC